BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15385799)

  • 1. Differentiation of human alloreactive CD4+ and CD8+ T cells in vitro.
    Nikolaeva N; Uss E; van Leeuwen EM; van Lier RA; ten Berge IJ
    Transplantation; 2004 Sep; 78(6):815-24. PubMed ID: 15385799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Pruning" of alloreactive CD4+ T cells using 5- (and 6-)carboxyfluorescein diacetate succinimidyl ester prolongs skin allograft survival.
    Watson D; Zhang GY; Sartor M; Alexander SI
    J Immunol; 2004 Dec; 173(11):6574-82. PubMed ID: 15557147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.
    Godfrey WR; Krampf MR; Taylor PA; Blazar BR
    Blood; 2004 Feb; 103(3):1158-65. PubMed ID: 14525783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin does not induce anergy but inhibits expansion and differentiation of alloreactive human T cells.
    Nikolaeva N; Bemelman FJ; Yong SL; van Lier RA; ten Berge IJ
    Transplantation; 2006 Feb; 81(3):445-54. PubMed ID: 16477233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human vascular endothelial cells stimulate a lower frequency of alloreactive CD8+ pre-CTL and induce less clonal expansion than matching B lymphoblastoid cells: development of a novel limiting dilution analysis method based on CFSE labeling of lymphocytes.
    Dengler TJ; Johnson DR; Pober JS
    J Immunol; 2001 Mar; 166(6):3846-54. PubMed ID: 11238628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of human alloreactive CD8(+) T cells in vitro.
    Rentenaar RJ; Vosters JL; van Diepen FN; Remmerswaal EB; van Lier RA; ten Berge IJ
    Immunology; 2002 Mar; 105(3):278-85. PubMed ID: 11918689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.
    Abate G; Eslick J; Newman FK; Frey SE; Belshe RB; Monath TP; Hoft DF
    J Infect Dis; 2005 Oct; 192(8):1362-71. PubMed ID: 16170753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester.
    Quah BJ; Warren HS; Parish CR
    Nat Protoc; 2007; 2(9):2049-56. PubMed ID: 17853860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CFSE to monitor ex vivo regulatory T-cell suppression of CD4+ and CD8+ T-cell proliferation within unseparated mononuclear cells from malignant and non-malignant human lymph node biopsies.
    Hilchey SP; Bernstein SH
    Immunol Invest; 2007; 36(5-6):629-48. PubMed ID: 18161522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiparameter flow cytometric approach for simultaneous evaluation of T lymphocyte-endothelial cell interactions.
    Krupnick AS; Kreisel D; Szeto WY; Popma SH; Amin KM; Moore JS; Rosengard BR
    Cytometry; 2001 Oct; 46(5):271-80. PubMed ID: 11746102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
    Takata H; Takiguchi M
    J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
    Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
    J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD27/CFSE-based ex vivo selection of highly suppressive alloantigen-specific human regulatory T cells.
    Koenen HJ; Fasse E; Joosten I
    J Immunol; 2005 Jun; 174(12):7573-83. PubMed ID: 15944257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric assessment of antigen-specific proliferation in peripheral chicken T cells by CFSE dilution.
    Dalgaard TS; Norup LR; Rubbenstroth D; Wattrang E; Juul-Madsen HR
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):85-94. PubMed ID: 20739071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of IL-15 addition on asbestos-induced suppression of human cytotoxic T lymphocyte induction.
    Kumagai-Takei N; Nishimura Y; Matsuzaki H; Lee S; Yoshitome K; Ito T; Otsuki T
    Environ Health Prev Med; 2021 Apr; 26(1):50. PubMed ID: 33874885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human decidual tissue contains differentiated CD8+ effector-memory T cells with unique properties.
    Tilburgs T; Schonkeren D; Eikmans M; Nagtzaam NM; Datema G; Swings GM; Prins F; van Lith JM; van der Mast BJ; Roelen DL; Scherjon SA; Claas FH
    J Immunol; 2010 Oct; 185(7):4470-7. PubMed ID: 20817873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
    Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
    J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic classification of human CD4+ T cell subsets and their differentiation.
    Okada R; Kondo T; Matsuki F; Takata H; Takiguchi M
    Int Immunol; 2008 Sep; 20(9):1189-99. PubMed ID: 18635582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
    Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
    Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.